These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9357446

  • 1. Linomide activates the adrenocortical axis in the rat: inhibition of experimental autoimmune encephalomyelitis by linomide is not related to the increase of corticosterone.
    Weidenfeld J, Karussis D, Abramsky O, Lehmann D, Arbell I, Ovadia H.
    J Neuroimmunol; 1997 Oct; 79(1):49-53. PubMed ID: 9357446
    [Abstract] [Full Text] [Related]

  • 2. The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids.
    Pekarski O, Björk J, Hedlund G, Andersson G.
    Autoimmunity; 1998 Oct; 28(4):235-41. PubMed ID: 9892505
    [Abstract] [Full Text] [Related]

  • 3. Linomide enhances apoptosis in CD4+CD8+ thymocytes.
    Harring AC, Xu Z, Andersson G, Hedlund G.
    Scand J Immunol; 1997 Nov; 46(5):488-94. PubMed ID: 9393631
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis.
    Lehmann D, Karussis DM, Fluresco D, Mizrachi-Koll R, Ovadia H, Shezen E, Kalland T, Abramsky O.
    J Neuroimmunol; 1997 Apr; 74(1-2):102-10. PubMed ID: 9119961
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the 2-deoxyglucose effect on the adrenocortical axis.
    Weidenfeld J, Corcos AP, Wohlman A, Feldman S.
    Endocrinology; 1994 Apr; 134(4):1924-31. PubMed ID: 8137760
    [Abstract] [Full Text] [Related]

  • 6. Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats.
    Zhu J, Diab A, Mustafa M, Levi M, Wahren B, Björk J, Hedlund G.
    J Neurol Sci; 1998 Oct 08; 160(2):113-20. PubMed ID: 9849793
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
    Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Ben-Nun A, Kalland T, Abramsky O.
    Ann Neurol; 1993 Nov 08; 34(5):654-60. PubMed ID: 8239559
    [Abstract] [Full Text] [Related]

  • 9. Corticosterone: narrow range required for normal body and thymus weight and ACTH.
    Akana SF, Cascio CS, Shinsako J, Dallman MF.
    Am J Physiol; 1985 Nov 08; 249(5 Pt 2):R527-32. PubMed ID: 2998210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunomodulation of experimental autoimmune myasthenia gravis with linomide.
    Karussis DM, Lehmann D, Brenner T, Wirguin I, Mizrachi-Koll R, Sicsic C, Abramsky O.
    J Neuroimmunol; 1994 Dec 08; 55(2):187-93. PubMed ID: 7829669
    [Abstract] [Full Text] [Related]

  • 12. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
    Karussis DM, Lehmann D, Slavin S, Vourka-Karussis U, Mizrachi-Koll R, Ovadia H, Kalland T, Abramsky O.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6400-4. PubMed ID: 8341645
    [Abstract] [Full Text] [Related]

  • 13. Linomide increases plasma corticosterone in normal rats, but does not prevent the inhibitory action of IL-1 on beta-cells in vivo or ex vivo.
    Christensen UB, Mauricio D, Reimers JI, Andersen HU, Kalland T, Nerup J, Mandrup-Poulsen T.
    Autoimmunity; 1996 Jul 15; 23(4):257-68. PubMed ID: 8915032
    [Abstract] [Full Text] [Related]

  • 14. Linomide-mediated protection of oligodendrocytes is associated with inhibition of nitric oxide production and IL-1beta expression in Lewis rat glial cells.
    Xiao BG, Bail XF, Zhang GX, Hedlund G, Link H.
    Neurosci Lett; 1998 Jun 12; 249(1):17-20. PubMed ID: 9672378
    [Abstract] [Full Text] [Related]

  • 15. Adrenalectomy in the neonate: adult-like adrenocortical system responses to both removal and replacement of corticosterone.
    Walker CD, Akana SF, Cascio CS, Dallman MF.
    Endocrinology; 1990 Aug 12; 127(2):832-42. PubMed ID: 2164922
    [Abstract] [Full Text] [Related]

  • 16. Glucocorticoid negative feedback on the HPA axis in five inbred rat strains.
    Gómez F, De Kloet ER, Armario A.
    Am J Physiol; 1998 Feb 12; 274(2):R420-7. PubMed ID: 9486300
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat.
    Stefferl A, Linington C, Holsboer F, Reul JM.
    Endocrinology; 1999 Nov 12; 140(11):4932-8. PubMed ID: 10537116
    [Abstract] [Full Text] [Related]

  • 18. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
    Karussis D, Abramsky O, Rosenthal Y, Mizrachi-Koll R, Ovadia H.
    Immunol Lett; 1999 Apr 15; 67(3):203-8. PubMed ID: 10369127
    [Abstract] [Full Text] [Related]

  • 19. Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening.
    Akana SF, Cascio CS, Du JZ, Levin N, Dallman MF.
    Endocrinology; 1986 Nov 15; 119(5):2325-32. PubMed ID: 3021439
    [Abstract] [Full Text] [Related]

  • 20. Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough.
    Walker CD, Scribner KA, Stern JS, Dallman MF.
    Endocrinology; 1992 Dec 15; 131(6):2629-37. PubMed ID: 1332842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.